CAMBRIDGE, Mass.--Molecular Dynamics and Amersham Pharmacia announced that the Hoechst-ARIAD Genomics Center here will collaborate with the two firms for continued development of new microarray technologies. Under the agreement, the center will provide funding and technical expertise while gaining early access to integrated microarray systems, related support, and training programs jointly developed by Molecular Dynamics and Amersham Pharmacia.
The center's researchers will receive microarray spotting and optical scanning instrumentation and software from Molecular Dynamics along with matched reagents and consumables from Amersham. Designed to help measure gene expression, identify new pharmaceutical targets, and measure therapeutic response, the microarray technology will directly support the Genomics Center's efforts to identify novel targets for small-molecule drug discovery and therapeutic proteins.